Page last updated: 2024-10-22

pimagedine and Dementia

pimagedine has been researched along with Dementia in 1 studies

pimagedine: diamine oxidase & nitric oxide synthase inhibitor; an advanced glycosylation end product inhibitor; used in the treatment of diabetic complications; structure
aminoguanidine : A one-carbon compound whose unique structure renders it capable of acting as a derivative of hydrazine, guanidine or formamide.

Dementia: An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rodrigues, L1
Biasibetti, R1
Swarowsky, A1
Leite, MC1
Quincozes-Santos, A1
Quilfeldt, JA1
Achaval, M1
Gonçalves, CA1

Other Studies

1 other study available for pimagedine and Dementia

ArticleYear
Hippocampal alterations in rats submitted to streptozotocin-induced dementia model are prevented by aminoguanidine.
    Journal of Alzheimer's disease : JAD, 2009, Volume: 17, Issue:1

    Topics: Analysis of Variance; Animals; Behavior, Animal; Dementia; Disease Models, Animal; Enzyme Inhibitors

2009